Largest Biotechnology Companies by Market Cap
Explore the biggest and most valuable companies in the Biotechnology sector ranked by market capitalization
Biotechnology Industry Market Cap: $1.47 Trillion Total Companies: 1,735
Total Market Cap (USD)
$1.47 Trillion
Companies Listed
1,735
Largest Company
Vertex Pharmaceuticals Inc
| Rank | Company | Market Cap (USD) | Market Cap (Local) | Country | Price | 24h Change | 7d Change | 24h Volume |
|---|---|---|---|---|---|---|---|---|
| 1 |
Vertex Pharmaceuticals Inc
NASDAQ:VRTX |
$118.01 Billion | $118.01 Billion | USA | $466.10 | -0.69% | +2.06% | 35.20 Million |
| 2 |
Regeneron Pharmaceuticals Inc
NASDAQ:REGN |
$74.58 Billion | $74.58 Billion | USA | $756.91 | +1.49% | -0.39% | 15.78 Million |
| 3 |
CSL Limited
PINK:CMXHF |
$63.46 Billion | $63.46 Billion | USA | $149.87 | -3.74% | -2.89% | 6.04K |
| 4 |
argenx SE
OTCGREY:ARGNF |
$42.99 Billion | $42.99 Billion | USA | $697.42 | +0.00% | +0.00% | 0.00 |
| 5 |
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY |
$42.14 Billion | $42.14 Billion | USA | $318.91 | +1.75% | -0.55% | 29.26 Million |
| 6 |
Argen-X
F:1AE |
$38.55 Billion | €37.56 Billion | Germany | €614.20 | +1.22% | -2.07% | 1.87K |
| 7 |
CSL Ltd
PINK:CSLLY |
$35.87 Billion | $35.87 Billion | USA | $74.44 | -7.01% | -5.97% | 898.05K |
| 8 |
BeiGene, Ltd.
NASDAQ:ONC |
$33.32 Billion | $33.32 Billion | USA | $289.65 | +1.97% | -3.81% | 6.23 Million |
| 9 |
Insmed Inc
NASDAQ:INSM |
$27.67 Billion | $27.67 Billion | USA | $144.60 | +3.66% | +3.19% | 54.08 Million |
| 10 |
UCB SA
PINK:UCBJF |
$20.38 Billion | $20.38 Billion | USA | $170.00 | -2.47% | -10.57% | 498.00 |
| 11 |
IVBIY
PINK:IVBIY |
$20.20 Billion | $20.20 Billion | USA | $22.29 | +0.00% | +16.42% | 320.00 |
| 12 |
Moderna Inc
NASDAQ:MRNA |
$19.64 Billion | $19.64 Billion | USA | $53.31 | +1.43% | +1.50% | 248.76 Million |
| 13 |
Royalty Pharma Plc
NASDAQ:RPRX |
$18.09 Billion | $18.09 Billion | USA | $46.10 | +0.99% | +1.52% | 79.94 Million |
| 14 |
Revolution Medicines Inc
NASDAQ:RVMD |
$17.23 Billion | $17.23 Billion | USA | $99.00 | +4.36% | +0.61% | 49.48 Million |
| 15 |
WuXi Biologics (Cayman) Inc
PINK:WXXWY |
$16.07 Billion | $16.07 Billion | USA | $5.68 | -10.13% | -15.85% | 343.96K |
| 16 |
Incyte Corporation
NASDAQ:INCY |
$15.49 Billion | $15.49 Billion | USA | $93.00 | +0.50% | -3.06% | 42.17 Million |
| 17 |
ROYALTY PHARMA OA DL-0001
F:RPD |
$15.01 Billion | €14.62 Billion | Germany | €39.02 | -0.31% | +2.17% | 3.20K |
| 18 |
Roivant Sciences Ltd
NASDAQ:ROIV |
$14.91 Billion | $14.91 Billion | USA | $28.28 | +0.78% | -1.74% | 137.21 Million |
| 19 |
REVOLUTION MED. DL-0001
F:42Z |
$14.74 Billion | €14.36 Billion | Germany | €82.50 | +0.61% | -2.94% | 1.10K |
| 20 |
Ascendis Pharma AS
NASDAQ:ASND |
$14.06 Billion | $14.06 Billion | USA | $231.03 | +2.23% | -4.00% | 17.90 Million |
| 21 |
WuXi Biologics
PINK:WXIBF |
$13.58 Billion | $13.58 Billion | USA | $3.70 | +0.00% | +0.00% | 0.00 |
| 22 |
Verona Pharma plc
F:I9SA |
$12.46 Billion | €12.13 Billion | Germany | €90.20 | +0.67% | +0.22% | 2.25K |
| 23 |
Ionis Pharmaceuticals Inc
NASDAQ:IONS |
$11.61 Billion | $11.61 Billion | USA | $72.34 | +1.62% | -2.30% | 55.22 Million |
| 24 |
Genmab A/S
PINK:GNMSF |
$11.33 Billion | $11.33 Billion | USA | $186.15 | -2.64% | -5.50% | 49.52K |
| 25 |
BridgeBio Pharma Inc
NASDAQ:BBIO |
$11.04 Billion | $11.04 Billion | USA | $71.03 | +2.33% | +8.68% | 70.82 Million |
| 26 |
Biomarin Pharmaceutical Inc
NASDAQ:BMRN |
$10.99 Billion | $10.99 Billion | USA | $57.43 | -1.85% | -6.04% | 55.94 Million |
| 27 |
Jazz Pharmaceuticals PLC
NASDAQ:JAZZ |
$10.86 Billion | $10.86 Billion | USA | $182.02 | +1.94% | +0.01% | 24.85 Million |
| 28 |
ALTEOGEN Inc
KQ:196170 |
$9.66 Billion | ₩14.14 Trillion | Korea | ₩355000.00 | -1.80% | -4.83% | 10.12 Million |
| 29 |
Innovent Biologics Inc
PINK:IVBXF |
$9.46 Billion | $9.46 Billion | USA | $6.15 | +0.00% | +15.38% | 7.07K |
| 30 |
Avidity Biosciences, Inc
NASDAQ:RNAM |
$9.43 Billion | $9.43 Billion | USA | $71.34 | +0.00% | +0.00% | 0.00 |
| 31 |
BioNTech SE
NASDAQ:BNTX |
$9.05 Billion | $9.05 Billion | USA | $90.54 | -0.71% | -10.80% | 32.64 Million |
| 32 |
Exelixis Inc
NASDAQ:EXEL |
$8.66 Billion | $8.66 Billion | USA | $41.07 | -0.41% | -1.16% | 70.74 Million |
| 33 |
Samsung Biologics Co Ltd
KO:207940 |
$8.08 Billion | ₩11.83 Trillion | Korea | ₩1000000.00 | +0.00% | +0.00% | 1.35 Million |
| 34 |
Blueprint Medicines Corp
NASDAQ:BPMC |
$7.77 Billion | $7.77 Billion | USA | $129.46 | +0.14% | +0.71% | 107.21 Million |
| 35 |
Bio-Techne Corp
NASDAQ:TECH |
$7.54 Billion | $7.54 Billion | USA | $48.81 | -4.01% | -9.43% | 56.83 Million |
| 36 |
Halozyme Therapeutics Inc
NASDAQ:HALO |
$7.47 Billion | $7.47 Billion | USA | $64.29 | +0.99% | -4.57% | 45.05 Million |
| 37 |
Cytokinetics Inc
NASDAQ:CYTK |
$7.39 Billion | $7.39 Billion | USA | $60.83 | +1.28% | +0.70% | 47.03 Million |
| 38 |
Vaxcyte Inc
NASDAQ:PCVX |
$7.36 Billion | $7.36 Billion | USA | $55.62 | +1.91% | -6.19% | 27.30 Million |
| 39 |
Akeso, Inc.
PINK:AKESF |
$7.27 Billion | $7.27 Billion | USA | $10.34 | -2.57% | +21.68% | 115.76K |
| 40 |
Axsome Therapeutics Inc
NASDAQ:AXSM |
$6.84 Billion | $6.84 Billion | USA | $158.23 | +1.38% | -2.53% | 13.82 Million |
| 41 |
Praxis Precision Medicines Inc
NASDAQ:PRAX |
$6.75 Billion | $6.75 Billion | USA | $305.00 | +3.76% | -1.84% | 9.42 Million |
| 42 |
Arrowhead Pharmaceuticals Inc
NASDAQ:ARWR |
$6.71 Billion | $6.71 Billion | USA | $57.37 | +4.21% | -4.10% | 54.99 Million |
| 43 |
Merus BV
NASDAQ:MRUS |
$6.30 Billion | $6.30 Billion | USA | $90.00 | -7.14% | -7.02% | 27.33 Million |
| 44 |
Krystal Biotech Inc
NASDAQ:KRYS |
$5.72 Billion | $5.72 Billion | USA | $250.16 | +1.17% | -1.39% | 6.56 Million |
| 45 |
VAXCYTE INC. DL -001
F:5VA |
$5.60 Billion | €5.46 Billion | Germany | €45.80 | -4.18% | -3.78% | 1.31K |
| 46 |
Cogent Biosciences Inc
NASDAQ:COGT |
$5.38 Billion | $5.38 Billion | USA | $35.68 | +4.94% | -3.78% | 40.62 Million |
| 47 |
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL |
$5.30 Billion | $5.30 Billion | USA | $440.83 | -0.90% | +1.85% | 8.22 Million |
| 48 |
ABL Bio Inc
KQ:298380 |
$5.21 Billion | ₩7.62 Trillion | Korea | ₩187000.00 | -0.53% | -1.73% | 15.85 Million |
| 49 |
Cidara Therapeutics Inc
NASDAQ:CDTX |
$5.12 Billion | $5.12 Billion | USA | $221.38 | +0.03% | +0.26% | 24.25 Million |
| 50 |
Rhythm Pharmaceuticals Inc
NASDAQ:RYTM |
$5.02 Billion | $5.02 Billion | USA | $90.51 | +3.58% | -3.22% | 18.70 Million |
| 51 |
Mirum Pharmaceuticals Inc
NASDAQ:MIRM |
$4.87 Billion | $4.87 Billion | USA | $92.64 | +2.18% | +7.35% | 18.44 Million |
| 52 |
Protagonist Therapeutics Inc
NASDAQ:PTGX |
$4.82 Billion | $4.82 Billion | USA | $96.75 | +4.75% | +5.06% | 13.96 Million |
| 53 |
Crispr Therapeutics AG
NASDAQ:CRSP |
$4.63 Billion | $4.63 Billion | USA | $48.42 | -0.68% | -14.30% | 52.12 Million |
| 54 |
Amicus Therapeutics Inc
NASDAQ:FOLD |
$4.48 Billion | $4.48 Billion | USA | $14.37 | +0.00% | +0.21% | 93.81 Million |
| 55 |
Nuvalent Inc
NASDAQ:NUVL |
$4.45 Billion | $4.45 Billion | USA | $99.53 | +1.63% | +0.12% | 11.28 Million |
| 56 |
CG Oncology, Inc. Common stock
NASDAQ:CGON |
$4.36 Billion | $4.36 Billion | USA | $65.90 | +2.50% | +6.50% | 27.97 Million |
| 57 |
Abivax SA American Depositary Shares
NASDAQ:ABVX |
$4.33 Billion | $4.33 Billion | USA | $122.75 | +6.28% | +12.27% | 20.85 Million |
| 58 |
3SBio Inc
F:83B |
$4.27 Billion | €4.16 Billion | Germany | €2.38 | +4.39% | +7.21% | 65.33K |
| 59 |
Tubize-Fin
BR:TUB |
$4.26 Billion | €4.15 Billion | Belgium | €216.00 | +1.89% | +0.00% | 544.78K |
| 60 |
CALIWAY BIOPHARMACEUTICALS CO L
TW:6919 |
$4.19 Billion | NT$138.72 Billion | Taiwan | NT$121.00 | -4.35% | -15.09% | 163.24 Million |
| 61 |
FIN.DE TUBIZE ACT.NOUV.
F:FTD |
$4.17 Billion | €4.06 Billion | Germany | €211.50 | -1.63% | -6.42% | 2.10K |
| 62 |
Metsera, Inc. Common Stock
NASDAQ:MTSR |
$4.12 Billion | $4.12 Billion | USA | $70.50 | +0.00% | -13.55% | 97.45 Million |
| 63 |
Arcellx Inc
NASDAQ:ACLX |
$4.04 Billion | $4.04 Billion | USA | $114.51 | +0.10% | +0.16% | 62.73 Million |
| 64 |
TG Therapeutics Inc
NASDAQ:TGTX |
$4.01 Billion | $4.01 Billion | USA | $28.77 | +2.90% | -1.71% | 39.42 Million |
| 65 |
Sino Biopharmaceutical Limited
PINK:SBMFF |
$4.00 Billion | $4.00 Billion | USA | $0.45 | +0.00% | +1.11% | 8.50K |
| 66 |
Akero Therapeutics Inc
NASDAQ:AKRO |
$3.89 Billion | $3.89 Billion | USA | $54.65 | +0.00% | +0.39% | 64.49 Million |
| 67 |
Abivax SA
PA:ABVX |
$3.88 Billion | €3.78 Billion | France | €107.20 | +5.93% | +14.04% | 2.86 Million |
| 68 |
Structure Therapeutics Inc. American Depositary Shares
NASDAQ:GPCR |
$3.87 Billion | $3.87 Billion | USA | $56.65 | +5.40% | -1.87% | 20.31 Million |
| 69 |
Kymera Therapeutics Inc
NASDAQ:KYMR |
$3.86 Billion | $3.86 Billion | USA | $79.60 | +0.72% | -4.66% | 18.73 Million |
| 70 |
Shanghai RAAS Blood Products Co Ltd Class A
SHE:002252 |
$3.76 Billion | CN¥27.62 Billion | China | CN¥6.21 | -0.32% | -0.48% | 624.29 Million |
| 71 |
ALK-ABELLO AS DK -50
F:4AJ0 |
$3.71 Billion | €3.61 Billion | Germany | €27.50 | -1.79% | -7.97% | 351.00 |
| 72 |
Apogee Therapeutics, Inc. Common Stock
NASDAQ:APGE |
$3.68 Billion | $3.68 Billion | USA | $71.09 | -1.13% | -2.68% | 18.96 Million |
| 73 |
Ligand Pharmaceuticals Incorporated
NASDAQ:LGND |
$3.62 Billion | $3.62 Billion | USA | $202.91 | -4.05% | -1.63% | 5.10 Million |
| 74 |
ADMA Biologics Inc
NASDAQ:ADMA |
$3.61 Billion | $3.61 Billion | USA | $15.84 | +4.55% | +2.92% | 79.86 Million |
| 75 |
MIRUM PHARMAC. DL-0001
F:08D |
$3.60 Billion | €3.51 Billion | Germany | €78.50 | +1.29% | +9.03% | 466.00 |
| 76 |
Celcuity LLC
NASDAQ:CELC |
$3.55 Billion | $3.55 Billion | USA | $114.90 | +0.60% | -0.09% | 14.73 Million |
| 77 |
LegoChem Biosciences Inc
KQ:141080 |
$3.51 Billion | ₩5.14 Trillion | Korea | ₩201000.00 | +0.00% | +0.90% | 10.18 Million |
| 78 |
SpringWorks Therapeutics Inc
NASDAQ:SWTX |
$3.48 Billion | $3.48 Billion | USA | $46.99 | +0.02% | +0.06% | 111.23 Million |
| 79 |
Zealand Pharma A/S
PINK:ZLDPF |
$3.46 Billion | $3.46 Billion | USA | $61.95 | -8.90% | -24.36% | 5.15K |
| 80 |
Viking Therapeutics Inc
NASDAQ:VKTX |
$3.35 Billion | $3.35 Billion | USA | $36.01 | +1.07% | +9.19% | 61.25 Million |
| 81 |
Scholar Rock Holding Corp
NASDAQ:SRRK |
$3.35 Billion | $3.35 Billion | USA | $40.26 | +0.62% | -11.11% | 27.68 Million |
| 82 |
AKERO THEREP.INC.DL-0001
F:0K4 |
$3.35 Billion | €3.26 Billion | Germany | €46.53 | -0.11% | -0.36% | 4.63K |
| 83 |
TERNS PHARMACEUT.DL-0001
F:430 |
$3.27 Billion | €3.19 Billion | Germany | €39.60 | -2.46% | +8.20% | 3.95K |
| 84 |
Legend Biotech Corp
NASDAQ:LEGN |
$3.25 Billion | $3.25 Billion | USA | $19.10 | +1.87% | +0.69% | 39.26 Million |
| 85 |
Xenon Pharmaceuticals Inc
NASDAQ:XENE |
$3.24 Billion | $3.24 Billion | USA | $54.66 | -1.03% | +30.33% | 45.72 Million |
| 86 |
Crinetics Pharmaceuticals Inc
NASDAQ:CRNX |
$3.21 Billion | $3.21 Billion | USA | $37.28 | -0.56% | -2.48% | 23.14 Million |
| 87 |
Hebei Changshan Biochem Pharma
SHE:300255 |
$3.20 Billion | CN¥23.45 Billion | China | CN¥41.82 | +0.02% | -2.52% | 437.43 Million |
| 88 |
Terns Pharmaceuticals Inc
NASDAQ:TERN |
$3.06 Billion | $3.06 Billion | USA | $46.07 | -0.97% | +7.59% | 47.32 Million |
| 89 |
Dianthus Therapeutics Inc.
NASDAQ:DNTH |
$3.05 Billion | $3.05 Billion | USA | $78.00 | +0.18% | +19.63% | 27.19 Million |
| 90 |
Asymchem Laboratories Tian Jin Co Ltd
SHE:002821 |
$3.00 Billion | CN¥21.98 Billion | China | CN¥99.08 | -0.23% | -0.23% | 82.73 Million |
| 91 |
Viridian Therapeutics Inc
NASDAQ:VRDN |
$2.94 Billion | $2.94 Billion | USA | $28.77 | +0.31% | +1.52% | 28.37 Million |
| 92 |
Shanghai Allist Pharmaceuticals Co. Ltd. A
SHG:688578 |
$2.90 Billion | CN¥21.24 Billion | China | CN¥94.51 | -0.37% | -2.00% | 103.23 Million |
| 93 |
Spyre Therapeutics Inc.
NASDAQ:SYRE |
$2.84 Billion | $2.84 Billion | USA | $44.07 | +10.48% | +9.76% | 19.25 Million |
| 94 |
Corcept Therapeutics Incorporated
NASDAQ:CORT |
$2.84 Billion | $2.84 Billion | USA | $32.18 | +0.09% | -4.99% | 39.70 Million |
| 95 |
Dyne Therapeutics Inc
NASDAQ:DYN |
$2.81 Billion | $2.81 Billion | USA | $18.13 | +1.17% | +22.01% | 52.93 Million |
| 96 |
LEGEND BIOTECH SP.ADS/2
F:9LB |
$2.81 Billion | €2.73 Billion | Germany | €16.50 | +0.61% | +2.48% | 5.99K |
| 97 |
SCHOLAR ROCK HLDG DL-001
F:2QK |
$2.78 Billion | €2.71 Billion | Germany | €35.00 | -2.23% | -11.62% | 2.20K |
| 98 |
Immunitybio Inc
NASDAQ:IBRX |
$2.76 Billion | $2.76 Billion | USA | $8.21 | -2.15% | -5.31% | 784.94 Million |
| 99 |
Erasca Inc
NASDAQ:ERAS |
$2.76 Billion | $2.76 Billion | USA | $13.51 | -0.81% | -12.67% | 99.90 Million |
| 100 |
Denali Therapeutics Inc
NASDAQ:DNLI |
$2.74 Billion | $2.74 Billion | USA | $20.57 | +0.00% | +4.47% | 36.47 Million |
| 101 |
ACADIA Pharmaceuticals Inc
NASDAQ:ACAD |
$2.71 Billion | $2.71 Billion | USA | $21.39 | +3.78% | -3.47% | 40.28 Million |
| 102 |
Catalyst Pharmaceuticals Inc
NASDAQ:CPRX |
$2.67 Billion | $2.67 Billion | USA | $23.30 | +0.30% | -3.88% | 28.44 Million |
| 103 |
PHARMARON BEIJING H YC1
F:17Q1 |
$2.67 Billion | €2.60 Billion | Germany | €2.14 | -1.83% | +0.00% | 7.66K |
| 104 |
Ideaya Biosciences Inc
NASDAQ:IDYA |
$2.65 Billion | $2.65 Billion | USA | $34.79 | +5.14% | +4.82% | 20.03 Million |
| 105 |
ALK-Abelló A/S
PINK:AKBLF |
$2.61 Billion | $2.61 Billion | USA | $19.90 | +0.00% | +0.00% | 10.00 |
| 106 |
Biocon Limited
NSE:BIOCON |
$2.58 Billion | ₹223.64 Billion | India | ₹383.55 | -2.21% | -0.84% | 79.46 Million |
| 107 |
Travere Therapeutics Inc
NASDAQ:TVTX |
$2.56 Billion | $2.56 Billion | USA | $28.03 | +0.83% | +2.90% | 31.84 Million |
| 108 |
Voronoi Co. Ltd.
KQ:310210 |
$2.46 Billion | ₩3.61 Trillion | Korea | ₩347500.00 | -4.40% | +5.46% | 2.75 Million |
| 109 |
Telix Pharmaceuticals Limited
PINK:TLPPF |
$2.42 Billion | $2.42 Billion | USA | $16.05 | -0.88% | -15.62% | 28.57K |
| 110 |
Belite Bio, Inc
F:D01 |
$2.37 Billion | €2.31 Billion | Germany | €143.00 | +0.00% | -2.72% | 2.27K |
| 111 |
Pharmaron Beijing Co., Ltd.
PINK:PHBBF |
$2.34 Billion | $2.34 Billion | USA | $1.93 | +0.00% | +0.00% | 0.00 |
| 112 |
IDEAYA BIOSCIENCE DL-01
F:30J |
$2.33 Billion | €2.27 Billion | Germany | €29.00 | +1.40% | +2.11% | 1.69K |
| 113 |
Ascentage Pharma Group International
NASDAQ:AAPG |
$2.25 Billion | $2.25 Billion | USA | $24.51 | +0.33% | +5.92% | 48.75K |
| 114 |
Zai Lab Ltd
NASDAQ:ZLAB |
$2.24 Billion | $2.24 Billion | USA | $19.06 | +3.76% | -2.46% | 14.15 Million |
| 115 |
Beam Therapeutics Inc
NASDAQ:BEAM |
$2.24 Billion | $2.24 Billion | USA | $25.49 | +1.31% | -3.96% | 44.10 Million |
| 116 |
Immunovant Inc
NASDAQ:IMVT |
$2.23 Billion | $2.23 Billion | USA | $25.00 | +2.42% | -6.23% | 25.36 Million |
| 117 |
Tarsus Pharmaceuticals Inc
NASDAQ:TARS |
$2.22 Billion | $2.22 Billion | USA | $68.90 | +1.38% | -5.95% | 14.92 Million |
| 118 |
Chongqing Zhifei Bio Products
SHE:300122 |
$2.19 Billion | CN¥16.07 Billion | China | CN¥16.40 | +1.36% | +1.49% | 410.56 Million |
| 119 |
Liquidia Technologies Inc
NASDAQ:LQDA |
$2.15 Billion | $2.15 Billion | USA | $35.70 | -2.62% | -0.92% | 44.01 Million |
| 120 |
Genscript Biotech Corporation
PINK:GNNSF |
$2.15 Billion | $2.15 Billion | USA | $1.57 | +4.26% | -7.94% | 3.79K |
| 121 |
OliX PharmaceuticalsInc
KQ:226950 |
$2.11 Billion | ₩3.09 Trillion | Korea | ₩186700.00 | -4.74% | -9.81% | 10.54 Million |
| 122 |
Camurus AB (publ)
OTCGREY:CAMRF |
$2.10 Billion | $2.10 Billion | USA | $59.98 | +0.00% | +0.00% | 0.00 |
| 123 |
Arcutis Biotherapeutics Inc
NASDAQ:ARQT |
$2.09 Billion | $2.09 Billion | USA | $22.76 | +0.04% | -5.17% | 29.95 Million |
| 124 |
Beijing Tiantan Biological Products Corp Ltd
SHG:600161 |
$2.03 Billion | CN¥14.93 Billion | China | CN¥16.04 | -0.43% | +2.56% | 212.61 Million |
| 125 |
Summit Therapeutics PLC
NASDAQ:SMMT |
$2.02 Billion | $2.02 Billion | USA | $16.18 | +0.34% | +7.05% | 50.89 Million |
| 126 |
Hualan Biological EngineeringInc
SHE:002007 |
$2.01 Billion | CN¥14.73 Billion | China | CN¥15.31 | +0.33% | +0.20% | 238.15 Million |
| 127 |
ASYMCHEM LAB.(TIAN.)H YC1
F:7K90 |
$1.98 Billion | €1.93 Billion | Germany | €8.70 | +0.00% | +0.58% | 1.38K |
| 128 |
Ultragenyx
NASDAQ:RARE |
$1.98 Billion | $1.98 Billion | USA | $21.82 | +2.25% | +2.68% | 48.71 Million |
| 129 |
LIQUIDIA CORP. DL-001
F:LT4 |
$1.97 Billion | €1.92 Billion | Germany | €31.96 | -1.42% | +8.56% | 67.41K |
| 130 |
Disc Medicine Inc.
NASDAQ:IRON |
$1.96 Billion | $1.96 Billion | USA | $60.89 | +1.42% | -0.47% | 21.28 Million |
| 131 |
LWB1
F:LWB1 |
$1.96 Billion | €1.90 Billion | Germany | €12.60 | -2.33% | -10.00% | 11.29K |
| 132 |
Mesoblast Ltd
NASDAQ:MESO |
$1.94 Billion | $1.94 Billion | USA | $14.63 | +0.55% | -7.70% | 6.51 Million |
| 133 |
Jinyu Bio-Technology Co Ltd
SHG:600201 |
$1.90 Billion | CN¥13.93 Billion | China | CN¥15.10 | +0.40% | +3.85% | 650.10 Million |
| 134 |
Suzhou Zelgen Biopharmaceuticals Co Ltd
SHG:688266 |
$1.89 Billion | CN¥13.86 Billion | China | CN¥78.95 | -2.29% | +1.62% | 71.78 Million |
| 135 |
CENTESSA PHARMACEUTICALS
F:260 |
$1.89 Billion | €1.84 Billion | Germany | €23.00 | +0.88% | +5.50% | 1.10K |
| 136 |
Caris Life Sciences, Inc. Common Stock
NASDAQ:CAI |
$1.86 Billion | $1.86 Billion | USA | $19.05 | +4.96% | +2.47% | 53.57 Million |
| 137 |
NewAmsterdam Pharma Company N.V. Ordinary Shares
NASDAQ:NAMS |
$1.86 Billion | $1.86 Billion | USA | $29.79 | +4.09% | -0.23% | 20.12 Million |
| 138 |
Ocular Therapeutix Inc
NASDAQ:OCUL |
$1.86 Billion | $1.86 Billion | USA | $8.63 | -1.48% | -15.97% | 199.21 Million |
| 139 |
Vera Therapeutics Inc
NASDAQ:VERA |
$1.84 Billion | $1.84 Billion | USA | $40.05 | +0.23% | +2.51% | 26.69 Million |
| 140 |
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH |
$1.84 Billion | $1.84 Billion | USA | $14.31 | +2.58% | -0.07% | 23.29 Million |
| 141 |
Sk Biopharmaceuticals Co Ltd
KO:326030 |
$1.83 Billion | ₩2.68 Trillion | Korea | ₩95600.00 | -2.25% | -7.09% | 6.51 Million |
| 142 |
Celldex Therapeutics Inc
NASDAQ:CLDX |
$1.82 Billion | $1.82 Billion | USA | $30.19 | +2.30% | +2.58% | 23.03 Million |
| 143 |
Xizang Haisco Pharmaceutical Group Co Ltd
SHE:002653 |
$1.81 Billion | CN¥13.27 Billion | China | CN¥48.87 | +5.46% | +3.82% | 84.53 Million |
| 144 |
Edgewise Therapeutics Inc
NASDAQ:EWTX |
$1.80 Billion | $1.80 Billion | USA | $29.78 | +0.64% | +7.05% | 19.85 Million |
| 145 |
Syndax Pharmaceuticals Inc
NASDAQ:SNDX |
$1.76 Billion | $1.76 Billion | USA | $24.04 | +2.30% | +8.93% | 31.18 Million |
| 146 |
Zymeworks Inc. Common Stock
NASDAQ:ZYME |
$1.75 Billion | $1.75 Billion | USA | $23.62 | +3.23% | -1.91% | 17.62 Million |
| 147 |
Alumis Inc
NASDAQ:ALMS |
$1.74 Billion | $1.74 Billion | USA | $26.20 | +5.60% | -2.60% | 30.93 Million |
| 148 |
Genus plc
PINK:GENSY |
$1.73 Billion | $1.73 Billion | USA | $26.54 | +0.00% | +0.00% | 0.00 |
| 149 |
OXFYY
PINK:OXFYY |
$1.73 Billion | $1.73 Billion | USA | $5.96 | +0.00% | +0.00% | 251.00 |
| 150 |
Definium Therapeutics, Inc.
NASDAQ:DFTX |
$1.72 Billion | $1.72 Billion | USA | $18.32 | +1.44% | +3.74% | 35.84 Million |
Track real-time market capitalization of largest public companies in the Biotechnology industry. Compare marketcap, analyze stock performance, and discover leading biotechnology corporations. View all industries